Support our sponsors:

NZX 50 Index	3326.74	2.10
S&P/ASX 200	4282.90	7.80
Dow Jones Industrials	12884.00	5.80

Twitter

Facebook

RSS

Daily ShareChat: Wakefield Health

By Jenny Ruth

Monday 15th June 2009

Text too small?

Wakefield Health is achieving sustained earnings growth from favourable demographics and capacity expansion both through organic growth and acquisitions, says McDouall Stuart.

The rapid growth in the aging population, particularly those over 85 years, is a strong macroeconomic driver while competition is weakening as public and not-for-profit hospitals come under increasing funding pressures and are unable to service the growing need, it says.

That is confirmed by the continued growth in private health insurance cover.

The company's strategy is to acquire additional hospitals and, after buying Bowen Hospital in 2004 and Royston Hospital in 2006, it is in continual discussions with other private hospitals throughout the country.

"The company has high operating leverage. Revenue growth, driven by volume and pricing, should ensure further improvement in return on capital employed," McDouall Stuart says.

Wakefield's near-term growth will be constrained by the proposed two stage development at Bowen Hospital which will encompass a new multi-level specialist facility and a new five-theatre complex to replace the existing three theatres, it says.

McDouall Stuart is forecasting net profit will rise from $10.1 million reported for the year ended March to $11.2 million next year and $11.6 million in 2010. It values the stock at $12.80 compared with last Friday's $9.25 share price.

BROKER CALL: McDouall Stuart rate Wakefield Health (NZX: WFD ) as buy.

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.